Results 21 to 30 of about 452,381 (401)
Rituximab in Membranous Nephropathy [PDF]
Kidney International Reports, 2021 Membranous nephropathy (MN) is the most common cause of primary nephrotic syndrome among adults. The identification of phospholipase A2 receptor (PLA2R) as target antigen in most patients changed the management of MN dramatically, and provided a rationale for B-cell depleting agents such as rituximab. The efficacy of rituximab in inducing remission has Philipp Gauckler, Jae Il Shin, Federico Alberici, Vincent Audard, Annette Bruchfeld, Martin Busch, Chee Kay Cheung, Matija Crnogorac, Elisa Delbarba, Kathrin Eller, Stanislas Faguer, Kresimir Galesic, Siân Griffin, Martijn W.F. van den Hoogen, Zdenka Hrušková, Anushya Jeyabalan, Alexandre Karras, Catherine King, Harbir Singh Kohli, Gert Mayer, Rutger Maas, Masahiro Muto, Sergey Moiseev, Balazs Odler, Ruth J. Pepper, Luis F. Quintana, Jai Radhakrishnan, Raja Ramachandran, Alan D. Salama, Ulf Schönermarck, Mårten Segelmark, Lee Smith, Vladimír Tesař, Jack Wetzels, Lisa Willcocks, Martin Windpessl, Ladan Zand, Reza Zonozi, Andreas Kronbichler, Philipp Gauckler, Jae Il Shin, Federico Alberici, Vincent Audard, Annette Bruchfeld, Martin Busch, Chee Kay Cheung, Matija Crnogorac, Elisa Delbarba, Kathrin Eller, Stanislas Faguer, Kresimir Galesic, Siân Griffin, Martijn W.F. van den Hoogen, Zdenka Hrušková, Anushya Jeyabalan, Alexandre Karras, Catherine King, Harbir Singh Kohli, Gert Mayer, Rutger Maas, Masahiro Muto, Sergey Moiseev, Balazs Odler, Ruth J. Pepper, Luis F. Quintana, Jai Radhakrishnan, Raja Ramachandran, Alan D. Salama, Ulf Schönermarck, Mårten Segelmark, Lee Smith, Vladimír Tesař, Jack Wetzels, Lisa Willcocks, Martin Windpessl, Ladan Zand, Reza Zonozi, Andreas Kronbichler +77 moreopenaire +13 more sourcesSDF4 Is a Prognostic Factor for 28-Days Mortality in Patients With Sepsis via Negatively Regulating ER Stress
Frontiers in Immunology, 2021 Sepsis is a heterogeneous syndrome induced by infection and results in high mortality. Even though more than 100 biomarkers for sepsis prognosis were evaluated, prediction of patient outcomes in sepsis continues to be driven by clinical signs because of ...Tingting Zhu, Tingting Zhu, Tingting Zhu, Qun Su, Cuili Wang, Cuili Wang, Cuili Wang, Lingling Shen, Lingling Shen, Lingling Shen, Hongjun Chen, Hongjun Chen, Hongjun Chen, Shi Feng, Shi Feng, Shi Feng, Xiaofeng Peng, Xiaofeng Peng, Xiaofeng Peng, Siyu Chen, Siyu Chen, Siyu Chen, Yucheng Wang, Yucheng Wang, Yucheng Wang, Hong Jiang, Hong Jiang, Hong Jiang, Jianghua Chen, Jianghua Chen, Jianghua Chen +30 moredoaj +1 more sourceUrinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes [PDF]
, 2013 Background: Patients with Type 1 Diabetes (T1D) are particularly vulnerable to development of Diabetic nephropathy (DN) leading to End Stage Renal Disease.A Krupa, A Micera, Analysis The Case for Objective Bayesian, AO Phillips, B John, Christos Argyropoulos, D Lunn, D Macconi, D Shan, David Galas, David Huang, Demetrius Ellis, DP Bartel, G Ghosh, G Togliatto, G Wang, G Wang, G Wang, H Guo, H Haller, H Sun, J Hou, JA Weber, JM Lorenzen, John Johnson, Jose Bernardo, K Bhatt, K Heese, K Sharma, Kai Wang, Karin Jandeleit-Dahm, L Denby, L Held, L Mahimainathan, L Matthews, M Ashburner, M Hackl, M Kato, M Kato, M Kato, ME Molitch, MW Pfaffl, O García-Sánchez, P Dentelli, P Kantharidis, P Ruggenenti, PE Pergola, R Bonofiglio, R Liao, RC Friedman, RC Gentleman, RC Lee, RW Carthew, S Fatima, Sara McClarty, SM Titan, SW Shan, T Roweis, Sam, TD Schmittgen, Trevor Orchard, U Tran, VA Valera, W Stacklies, X Wang, X-Y Bai, Y Dai, YS Kanwar, Z Chun-Zhi +67 morecore +8 more sourcesCase Report: Pathogenic MYH9 c.5797delC Mutation in a Patient With Apparent Thrombocytopenia and Nephropathy
Frontiers in Genetics, 2021 MYH9-related disease or disorder (MYH9-RD) is an autosomal dominant disease caused by mutations in the MYH9 gene. Mutations in this gene initially affect the hemic system, and other manifestations may evolve with age.Pingping Ren, Pingping Ren, Pingping Ren, Hongjun Chen, Hongjun Chen, Hongjun Chen, Yucheng Wang, Yucheng Wang, Yucheng Wang, Cuili Wang, Cuili Wang, Cuili Wang, Shi Feng, Shi Feng, Shi Feng, Hong Jiang, Hong Jiang, Hong Jiang, Jianghua Chen, Jianghua Chen, Jianghua Chen +20 moredoaj +1 more sourceCanagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
New England Journal of Medicine, 2019 BACKGROUND
Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium-glucose cotransporter 2 (SGLT2), exploratory results have ...V. Perkovic, M. Jardine, B. Neal, Severine Bompoint, H. Heerspink, D. Charytan, Robert Edwards, R. Agarwal, G. Bakris, S. Bull, C. Cannon, G. Capuano, P. Chu, D. de Zeeuw, T. Greene, A. Levin, C. Pollock, D. Wheeler, Yshai Yavin, Hong Zhang, B. Zinman, G. Meininger, B. Brenner, K. Mahaffey +23 moresemanticscholar +1 more sourceVogt-Koyanagi-Harada Syndrome in Two Patients with Immunoglobulin A Nephropathy [PDF]
, 2007 We describe herein 2 patients who developed Vogt-Koyanagi-Harada syndrome in the course of renal biopsy-proven immunoglobulin A (IgA) nephropathy. A 61-year-old man with an 11-year history of IgA nephropathy and a 16-year history of thyroiditis, and a 56-Masuda, Ikuya, Matsuo, Toshihiko, Nose, Soichiro, Ota, Kosuke, Sunami, Reiko, Yamadori, Ichiro +5 morecore +1 more sourceRenoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.
New England Journal of Medicine, 2001 BACKGROUND
It is unknown whether either the angiotensin-II-receptor blocker irbesartan or the calcium-channel blocker amlodipine slows the progression of nephropathy in patients with type 2 diabetes independently of its capacity to lower the systemic ...E. Lewis, L. Hunsicker, W. Clarke, T. Berl, M. Pohl, J. Lewis, E. Ritz, R. Atkins, R. Rohde, I. Raz +9 moresemanticscholar +1 more sourceGenome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus [PDF]
, 2010 BACKGROUND: Diabetic nephropathy is a serious complication of diabetes mellitus and is associated with considerable morbidity and high mortality.A Buja, A Helgadottir, A Subramanian, AE Teschendorff, Alexander P Maxwell, Andrew E Teschendorff, AS O'Connor, B He, B Krause, BH Ramsahoye, C Weigert, Christopher G Bell, D Ansell, D Ingrosso, DA Tregouet, David A Savage, EJ Richards, ER Seaquist, F Eckhardt, G Lund, H Al-Kateb, H Makino, HN Ibrahim, JD Storey, JF Navarro-Gonzalez, JJ Rogus, JT Leek, K Ichinose, M Bibikova, M Bibikova, M Quinn, MG Pezzolesi, MG Pezzolesi, MM Suzuki, MP Turunen, NM Goldenberg, P Katavetin, R Ihaka, R Lister, R Sladek, RA Irizarry, RC Gentleman, S Beck, S Saxonov, Stephan Beck, T Hastie, TA Down, TJ Ekstrom, TS Leak, U.S Renal Data System, Vardhman K Rakyan +50 morecore +4 more sources